Showing results (51-60 of 97) with videos related to
Sort By:
Pageof 10
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 30, 2012
Evaluation of new immunological targets in neuromyelitis opticaJean-Baptiste Chanson, Ilaria Paolini, Nicolas Collongues, et al.Neurology|March 15, 2020
Evaluation of efficacy and tolerability of first-line therapies in NMOSDJulien Poupart, Jonathan Giovannelli, Romain Deschamps, et al.Plos One|April 18, 2012
White matter atrophy and cognitive dysfunctions in neuromyelitis opticaFrederic Blanc, Vincent Noblet, Barbara Jung, et al.Neurology|June 8, 2023
Rituximab De-escalation in Patients With Neuromyelitis Optica Spectrum DisorderStanislas Demuth, Nicolas Collongues, Bertrand Audoin, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 5, 2023
Time to steroids impacts visual outcome of optic neuritis in MOGADJulie Rode, Julie Pique, Adil Maarouf, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 15, 2025
Evaluation of the predictive value of CSF-restricted oligoclonal bands on residual disability and risk of relapse in adult patients with MOGAD: MOGADOC studyRyan Ramdani, Julie Pique, Romain Deschamps, et al.Journal of Magnetic Resonance Imaging : JMRI|October 24, 2018
Measurement of magnetization transfer ratio (MTR) from cervical spinal cord: Multicenter reproducibility and variabilityBenoit Combès, Laureline Monteau, Elise Bannier, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2016
Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disordersAlexis Montcuquet, Nicolas Collongues, Caroline Papeix, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 27, 2022
Pure Relapsing Short Myelitis: Part of the Multiple Sclerosis Spectrum or New Entity?Zélia Poullet, Julie Pique, Adil Maarouf, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 19, 2025
European experience of cladribine tablets in elderly patients with multiple sclerosis: Could it be the last treatment?Jérôme de Seze, Chiara Zecca, Giovanni Castelnovo, et al.Pageof 10